胃潰瘍の病気が発症する.
Peter Malfertheiner1, Francis K L Chan, Kenneth E L McColl
1Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Germany. peter.malfertheiner@med.ovgu.de
Lancet (London, England)
|August 18, 2009
まとめ
胃潰瘍疾患の発生率は,酸性抑制剤とヘリコバクター・パイロリ治療の進歩により減少しています. しかし,非ステロイド性抗炎症薬 (NSAIDs) とアスピリンは依然として潰瘍を引き起こすため,継続的な管理戦略を必要とします.
科学分野:
- 胃腸内科 胃腸内科
- エピデミオロジー エピデミオロジー
- 薬理学 薬理学とは
背景:
- 胃潰瘍病は,歴史上,著しい罹病率と死亡率を引き起こしてきました.
- 近年,胃潰瘍病の発生率が著しく減少していることが示されています.
- 重要な要因には,強力な酸性抑制剤とヘリコバクター・ピロリ菌の発見が含まれます.
研究 の 目的:
- 過去25年間の胃潰瘍疾患の理解と管理における革命を振り返る.
- 非ステロイド性抗炎症薬 (NSAIDs) と低用量アスピリンの潰瘍病への影響を調査する.
- 薬剤誘発性潰瘍およびH. pylori陰性,NSAID陰性潰瘍に対する戦略について議論する.
主な方法:
- 胃潰瘍疾患における疫学的傾向のレビュー.
- ヘリコバクター・パイロリ発見が病気の理解と治療に与える影響の分析.
- 現在の潰瘍の病原性におけるNSAIDとアスピリンの役割の検討.
- 薬物誘発性潰瘍に対する治療と予防戦略の議論.
主要な成果:
- 胃潰瘍の病率の大幅な減少は,酸性抑制剤とH. pyloriの根絶に起因する.
- 非ステロイド性抗炎症薬 (NSAID) と低用量アスピリンは,現在,胃潰瘍の主要な原因となっています.
- H. pylori 陰性,NSAID 陰性潰瘍は,希少だが増大する臨床的課題を代表しています.
結論:
- 医学における進歩は,胃潰瘍疾患の管理に変革をもたらしました.
- NSAIDとアスピリンの使用は,潰瘍疾患を駆動し続けているため,標的型の予防と治療が必要です.
- 複雑な潰瘍の症例,H. pylori陰性,NSAID陰性潰瘍などの管理のためにさらなる研究が必要です.
関連する概念動画
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
